Latest Gene therapy Stories
Lack of Disease-Modifying Therapies is Expected to Remain a Critical Unmet Need and Provides Ample Opportunity for Developers, According to Findings from Decision Resources Group BURLINGTON,
SAN DIEGO, June 12, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc.
Internationally recognized physician-scientists joining fight against devastating childhood diseases as hospital expands clinical and basic science research MEMPHIS, Tenn., June 10,
Barbara and Edward Netter awarded prestigious distinction by the American Society of Gene and Cell Therapy. Washington, DC (PRWEB) June 05, 2014 Barbara
Eighth-annual Greenwich-Stamford Open Water Swim unites Connecticut residents in the fight against cancer. Stamford, CT (PRWEB) June 03, 2014 Across
PHILADELPHIA, June 2, 2014 /PRNewswire/ -- Spark Therapeutics, Inc., a late-stage gene therapy company developing treatments for a wide range of rare, debilitating diseases, announced today that company
Groundbreaking Nature Publication Describes Successful ZFN Driven Genome Editing in Long-Term Repopulating Stem Cells Necessary for Clinical Translation RICHMOND, Calif., May 28, 2014
Gene therapy leader to advance its deep pipeline of rare disease programs including its lead Phase 3 product candidate for RPE65-related blindness PHILADELPHIA, May 27, 2014 /PRNewswire/
For the first time researchers have succeeded in altering HIV virus particles so that they can simultaneously, as it were, 'cut and paste' in our genome via biological processes.
SB-728-T-Treated Subject Maintains Control of Viral Load for 45 Weeks Without Anti-Retroviral Drugs RICHMOND, Calif., May 27, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
- a slit in a tire to drain away surface water and improve traction.
More Images (1 images) »